Large-cap Health Care company CVS Health has moved 2.3% so far today on a volume of 1,121,625, compared to its average of 9,304,670. In contrast, the S&P 500 index moved 0.0%.
CVS Health trades -32.54% away from its average analyst target price of $112.71 per share. The 21 analysts following the stock have set target prices ranging from $95.0 to $143.0, and on average have given CVS Health a rating of buy.
Anyone interested in buying CVS should be aware of the facts below:
-
CVS Health's current price is -2.1% below its Graham number of $77.68, which implies the stock has a margin of safety
-
CVS Health has moved -25.7% over the last year, and the S&P 500 logged a change of -10.3%
-
Based on its trailing earnings per share of 3.14, CVS Health has a trailing 12 month Price to Earnings (P/E) ratio of 24.2 while the S&P 500 average is 15.97
-
CVS has a forward P/E ratio of 8.4 based on its forward 12 month price to earnings (EPS) of $9.07 per share
-
The company has a price to earnings growth (PEG) ratio of 1.52 — a number near or below 1 signifying that CVS Health is fairly valued compared to its estimated growth potential
-
Its Price to Book (P/B) ratio is 1.4 compared to its sector average of 4.16
-
CVS Health Corporation provides health services in the United States.
-
Based in Woonsocket, the company has 219,000 full time employees and a market cap of $97,630,879,744. CVS Health currently returns an annual dividend yield of 3.0%.